drugset / Trial / NCT03151967

Lactobacillus Probiotic for Prevention of UTI

NCT03151967

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this research is to see whether LACTIN-V (Lactobacillus crispatus CTV-05) is an effective method of preventing recurrent urinary tract infections (UTI's) and to learn the side effects of LACTIN-V. LACTIN-V is a vaginal applicator that contains Lactobacillus crispatus, an organism found naturally in the vaginas of healthy women. Lactobacillus bacteria are thought to help prevent other bacteria such as E. coli from causing UTI's. This is a double blind study comparing active product to a placebo (inactive vaginal applicator without any medicine).

Timeline

Start
2015-09
Primary completion
2017-04-05
Completion
2017-04-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator LACTIN-V Other / unclassified